GGrantIndex
Sort

59,101 grants matching hypertension

Per- and Polyfluoroalkyl substances mixtures and maternal cardiovascular disease risk across the reproductive life course

$623,222
Tamarra M James-Todd · Harvard School Of Public Health · R01 · FY2021 · ES

Biobehavioral Studies of Obesity, Weight loss and Recidivism

$623,171
Monica Skarulis · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Low-level Arsenic Exposure and Cardiovascular Disease in Multi-Ethnic Adults (MESA As)

$623,162
Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2019 · ES

Smooth Muscle Mineralocorticoid Receptors in Vascular Aging and Hypertension

$623,160
Iris Z Jaffe · Tufts Medical Center · R01 · FY2016 · HL

Pragmatic trial of behavioral interventions for insomnia in hypertensive patients

$623,122
Daniel J Buysse · University Of Pittsburgh At Pittsburgh · UH3 · FY2018 · HL

Novel imprint control regions (ICRs) responsive to environmental exposures

$623,055
Cathrine Hoyo · North Carolina State University Raleigh · R01 · FY2021 · ES

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women

$623,042
Richard S. Legro · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · HD

Longitudinal Associations of Midlife Sleep Duration and Quality with Later Life Cognitive and Physical Functioning Decline

$622,954
Erika W Hagen · University Of Wisconsin-Madison · R01 · FY2019 · AG

MINNESOTA STROKE SURVEY

$622,929
University Of Minnesota Twin Cities · R01 · FY2002 · NS

Aldosterone Synthase & Hypertension

$622,916
Ashok Kumar Kumar · University Of Toledo Health Sci Campus · R01 · FY2015 · HL

Natural History of Sickle Cell Disease and Other Hemolytic Disorders

$622,888
Gregory Kato · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

Environmental Oxidant Stressors in Pediatric Chronic Kidney Disease - Resubmissio

$622,884
Leonardo Trasande · New York University School Of Medicine · R01 · FY2015 · DK

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

$622,831
Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · DK

Hypertension Control & Therapy Adherence

$622,806
Nancy R. Kressin · Boston Medical Center · R01 · FY2006 · HL

Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease

$622,786
Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2011 · HL

Metabolic and Inflammatory Pathways of Midlife Neurocognitive Disparities

$622,772
Anna L. Marsland · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK

A Personalized Metabolomic Approach to Human Obesity and Weight Loss

$622,766
Svati H. Shah · Duke University · R01 · FY2016 · HL

Obesity & OSA: Understanding the Importance of Tongue Fat and Metabolic Function

$622,758
Richard J. Schwab · University Of Pennsylvania · R01 · FY2008 · HL

Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults

$622,745
Sudha Seshadri · University Of Texas Hlth Science Center · R01 · FY2018 · AG

Alzheimer Caregiver Coping: Mental and Physical Health

$622,706
University Of California San Diego · R01 · FY2001 · AG

Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)

$622,706
Jordana B. Cohen · University Of Pennsylvania · R01 · FY2024 · HL

VIDA: Virtual Diabetes Group Visits Across Health Systems

$622,687
Arshiya Ahmed Baig · University Of Chicago · P50 · FY2022 · MD

Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease

$622,648
Josef Coresh · Johns Hopkins University · R01 · FY2011 · DK

Reducing maternal prenatal depression to improve child cardiovascular health

$622,603
Elysia Poggi Davis · University Of Denver (Colorado Seminary) · R01 · FY2021 · HL

Safety of Combinatorial Therapy with Erythropoietin and Melatonin for Preterm Infants with Intraventricular Hemorrhage

$622,537
Shenandoah Robinson · Johns Hopkins University · R01 · FY2022 · HD